APA citiranje

Attard, G., Reid, A. H., A’Hern, R., Parker, C., Oommen, N. B., Folkerd, E., . . . de Bono, J. S. (2009). Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer.

Citação norma Chicago

Attard, Gerhardt, et al. Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer. 2009.

MLA citiranje

Attard, Gerhardt, et al. Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer. 2009.